These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10933775)

  • 1. Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba.
    Lim L; Coster DJ; Badenoch PR
    Clin Exp Ophthalmol; 2000 Apr; 28(2):119-24. PubMed ID: 10933775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistently culture positive acanthamoeba keratitis: in vivo resistance and in vitro sensitivity.
    Pérez-Santonja JJ; Kilvington S; Hughes R; Tufail A; Matheson M; Dart JK
    Ophthalmology; 2003 Aug; 110(8):1593-600. PubMed ID: 12917179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a practical complete-kill assay to evaluate anti-Acanthamoeba drugs.
    Kowalski RP; Abdel Aziz S; Romanowski EG; Shanks RM; Nau AC; Raju LV
    JAMA Ophthalmol; 2013 Nov; 131(11):1459-62. PubMed ID: 24077460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and application of an in vitro susceptibility test for Acanthamoeba species isolated from keratitis to polyhexamethylene biguanide and chlorhexidine.
    Narasimhan S; Madhavan HN; K LT
    Cornea; 2002 Mar; 21(2):203-5. PubMed ID: 11862096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
    Elder MJ; Kilvington S; Dart JK
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1059-64. PubMed ID: 8125716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reculture technique: individualizing the treatment of Acanthamoeba keratitis.
    Wysenbeek YS; Blank-Porat D; Harizman N; Wygnanski-Jaffe T; Keller N; Avni I
    Cornea; 2000 Jul; 19(4):464-7. PubMed ID: 10928758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
    Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
    Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
    Larkin DF; Kilvington S; Dart JK
    Ophthalmology; 1992 Feb; 99(2):185-91. PubMed ID: 1553206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of effective treatment drugs against Acanthamoeba cyst].
    Tahara K; Asari S; Shimomura Y; Endo T; Yanagihara T
    Kansenshogaku Zasshi; 1997 Oct; 71(10):1025-30. PubMed ID: 9394554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial action of biguanides on the viability of Acanthamoeba cysts and assessment of cell toxicity.
    Mafra CS; Carrijo-Carvalho LC; Chudzinski-Tavassi AM; Taguchi FM; Foronda AS; Carvalho FR; de Freitas D
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6363-72. PubMed ID: 23900604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of povidone iodine, chlorhexidine digluconate and toyocamycin on amphizoic amoebic strains, infectious agents of
    Padzik M; Baltaza W; Conn DB; Szaflik JP; Chomicz L
    Ann Agric Environ Med; 2018 Dec; 25(4):725-731. PubMed ID: 30586959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy Testing of Antiamoebic Agents for Acanthamoeba: Antagonistic Effect of Voriconazole.
    Talbott M; Cevallos V; Chen MC; Chin SA; Lalitha P; Seitzman GD; Lietman TM; Keenan JD
    Cornea; 2019 Oct; 38(10):1309-1313. PubMed ID: 31306283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of In Vitro Antiamoebic Activity of Antimicrobial Agents Against Clinical Acanthamoeba Isolates.
    Nakaminami H; Tanuma K; Enomoto K; Yoshimura Y; Onuki T; Nihonyanagi S; Hamada Y; Noguchi N
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):629-634. PubMed ID: 28704121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful medical treatment of Acanthamoeba keratitis.
    Azuara-Blanco A; Sadiq AS; Hussain M; Lloyd JH; Dua HS
    Int Ophthalmol; 1997-1998; 21(4):223-7. PubMed ID: 9700010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyhexamethylene biguanide treatment for Acanthamoeba keratitis.
    Sullivan L
    Aust N Z J Ophthalmol; 1998 Feb; 26(1):99. PubMed ID: 9524039
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic agents and biocides for ocular infections by free-living amoebae of Acanthamoeba genus.
    Carrijo-Carvalho LC; Sant'ana VP; Foronda AS; de Freitas D; de Souza Carvalho FR
    Surv Ophthalmol; 2017; 62(2):203-218. PubMed ID: 27836717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of antimicrobial compounds for cysticidal activity against Acanthamoeba.
    Osato MS; Robinson NM; Wilhelmus KR; Jones DB
    Rev Infect Dis; 1991; 13 Suppl 5():S431-5. PubMed ID: 2047690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of Acanthamoeba keratitis by hexamidine.
    Brasseur G; Favennec L; Perrine D; Chenu JP; Brasseur P
    Cornea; 1994 Sep; 13(5):459-62. PubMed ID: 7995072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.